,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Sinus tachycardia,6,16188823
1,22.0,Acute kidney injury,2,16188823
2,22.0,Diarrhoea,1,16188823
3,22.0,Left ventricular hypertrophy,6,16188823
4,22.0,Lactic acidosis,1,16188823
0,22.0,Retinal pigment epitheliopathy,6,16188835
1,22.0,Retinal detachment,6,16188835
2,22.0,Blindness,6,16188835
3,22.0,Choroidal sclerosis,6,16188835
4,22.0,Deposit eye,6,16188835
5,22.0,Visual impairment,6,16188835
0,22.0,Death,5,16188848
0,22.0,Malignant neoplasm progression,5,16188874
1,22.0,Decreased appetite,1,16188874
2,22.0,Hypoaesthesia,1,16188874
3,22.0,Arthralgia,1,16188874
4,22.0,Fatigue,1,16188874
5,22.0,Thirst,2,16188874
0,22.0,Hypokalaemia,1,16188875
1,22.0,Fatigue,1,16188875
2,22.0,Neutropenia,1,16188875
3,22.0,Nausea,1,16188875
4,22.0,Febrile infection,6,16188875
5,22.0,Diarrhoea,1,16188875
6,22.0,Anaemia,1,16188875
0,22.0,Death,,16188926
0,22.0,Death,,16188936
0,22.0,Disease progression,,16188939
0,22.0,Malignant neoplasm progression,5,16188966
1,22.0,Constipation,3,16188966
2,22.0,Respiratory failure,5,16188966
3,22.0,Tongue discomfort,6,16188966
4,22.0,Fatigue,6,16188966
5,22.0,Dry skin,6,16188966
6,22.0,Vomiting,6,16188966
7,22.0,Joint swelling,6,16188966
8,22.0,Feeding disorder,3,16188966
9,22.0,Abdominal pain,3,16188966
0,22.0,Pulmonary mass,,16188976
0,22.0,Disease progression,,16188990
0,22.0,Bone marrow failure,6,16188992
1,22.0,Dyspnoea,6,16188992
2,22.0,Asthenia,6,16188992
0,22.0,Atrial fibrillation,6,16188996
0,22.0,Gastrointestinal disorder,6,16189008
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16189008
0,22.1,Neoplasm progression,6,16189030
1,22.1,Condition aggravated,6,16189030
2,22.1,Breast mass,6,16189030
3,22.1,Seizure,6,16189030
0,22.0,Lymphoedema,3,16189101
1,22.0,Herpes zoster,1,16189101
2,22.0,Oral herpes,1,16189101
3,22.0,Anaemia,1,16189101
4,22.0,Humerus fracture,1,16189101
0,22.0,Visual impairment,6,16189124
0,22.0,Fatigue,6,16189128
0,22.0,Death,5,16189130
0,22.0,Gastrointestinal disorder,2,16189247
1,22.0,White blood cell count decreased,2,16189247
0,22.0,Renal failure,6,16189260
0,22.0,Pneumonia,1,16189293
1,22.0,Anaemia,1,16189293
2,22.0,Diarrhoea,1,16189293
0,22.0,Disease progression,,16189305
0,22.0,Myalgia,,16189310
1,22.0,Osteonecrosis,,16189310
0,22.0,Hypotension,6,16189335
1,22.0,Ammonia increased,6,16189335
2,22.0,Anaemia,6,16189335
3,22.0,Dehydration,6,16189335
4,22.0,Ascites,6,16189335
0,22.0,Blindness unilateral,3,16189349
1,22.0,Product use in unapproved indication,6,16189349
2,22.0,Optic neuritis,3,16189349
3,22.0,Facial paralysis,3,16189349
0,22.0,Death,5,16189360
0,22.0,Drug hypersensitivity,,16189367
1,22.0,Hospitalisation,,16189367
0,22.0,Death,5,16189396
0,22.0,Cystitis,3,16189402
1,22.0,Hypothyroidism,2,16189402
2,22.0,Abdominal infection,2,16189402
3,22.0,Abscess,2,16189402
0,22.0,Myocardial infarction,5,16189424
0,22.0,Blood pressure decreased,,16189653
1,22.0,Oxygen saturation decreased,,16189653
2,22.0,Vital functions abnormal,,16189653
0,22.0,Proteinuria,3,16189669
1,22.0,Gastrointestinal toxicity,6,16189669
2,22.0,Gastrointestinal disorder,1,16189669
0,22.0,Death,5,16189675
0,22.0,Febrile neutropenia,1,16189689
0,22.0,Death,5,16189709
0,22.0,Hypocalcaemia,2,16189767
0,22.0,Death,5,16189777
0,22.0,Cardiac arrest,1,16189779
1,22.0,Congestive cardiomyopathy,3,16189779
2,22.0,Ventricular fibrillation,1,16189779
0,22.0,Death,5,16189878
0,22.0,Death,5,16190111
1,22.0,Osteonecrosis of jaw,3,16190111
0,22.0,Osteonecrosis,6,16190189
1,22.0,Osteoarthritis,6,16190189
2,22.0,Bone swelling,6,16190189
3,22.0,Arthralgia,6,16190189
4,22.0,Bone infarction,6,16190189
5,22.0,Post procedural oedema,6,16190189
0,22.0,Type 2 diabetes mellitus,4,16190205
0,22.0,Blood creatinine increased,4,16190213
1,22.0,Sepsis,4,16190213
2,22.0,Acute kidney injury,4,16190213
3,22.0,Anaemia,4,16190213
0,22.1,Fatigue,1,16190237
1,22.1,Adrenal insufficiency,2,16190237
2,22.1,Hypothyroidism,3,16190237
3,22.1,Pulmonary mass,6,16190237
4,22.1,Pneumonia bacterial,1,16190237
5,22.1,Neuropathy peripheral,1,16190237
6,22.1,Pyrexia,2,16190237
7,22.1,Dyspnoea,1,16190237
0,22.0,Metastases to peritoneum,6,16190403
1,22.0,Hydronephrosis,6,16190403
2,22.0,Renal impairment,3,16190403
0,22.0,Bone marrow failure,6,16190479
1,22.0,Gastrointestinal disorder,6,16190479
0,22.0,Madarosis,3,16190483
1,22.0,Hair colour changes,3,16190483
2,22.0,Hair disorder,3,16190483
3,22.0,Alopecia,3,16190483
4,22.0,Hair texture abnormal,3,16190483
0,22.0,Malaise,1,16190538
1,22.0,Wheezing,1,16190538
2,22.0,Fatigue,1,16190538
3,22.0,Dyspnoea,1,16190538
0,22.0,Oedema peripheral,2,16190541
1,22.0,Cardiac failure acute,2,16190541
0,22.0,Chills,1,16190544
1,22.0,Abdominal pain,1,16190544
2,22.0,Agranulocytosis,1,16190544
3,22.0,Folliculitis,1,16190544
4,22.0,Diarrhoea,1,16190544
5,22.0,Pyrexia,1,16190544
0,22.1,Oxygen saturation decreased,1,16190548
1,22.1,Dysphagia,1,16190548
2,22.1,Nausea,1,16190548
3,22.1,Somnolence,1,16190548
4,22.1,Hot flush,1,16190548
5,22.1,Dyspnoea,1,16190548
0,22.0,Blood magnesium decreased,1,16190550
1,22.0,Body temperature decreased,1,16190550
2,22.0,Malaise,1,16190550
0,22.0,Neoplasm progression,5,16190552
0,22.0,Death,5,16190560
0,22.0,Neoplasm progression,5,16190613
0,22.0,Myocarditis,1,16190619
0,22.0,Product use issue,6,16190642
1,22.0,Lung disorder,6,16190642
0,22.1,Hair colour changes,6,16190655
1,22.1,Hair texture abnormal,6,16190655
2,22.1,Hair disorder,6,16190655
3,22.1,Madarosis,3,16190655
4,22.1,Alopecia,3,16190655
0,22.0,Acute coronary syndrome,2,16190678
0,22.0,Microangiopathic haemolytic anaemia,6,16190682
1,22.0,Arteriosclerosis,6,16190682
2,22.0,Acute kidney injury,6,16190682
3,22.0,Blood creatinine increased,6,16190682
4,22.0,Systemic scleroderma,6,16190682
5,22.0,Activated partial thromboplastin time prolonged,6,16190682
6,22.0,Cardiac arrest,5,16190682
7,22.0,Thrombocytopenia,6,16190682
8,22.0,Platelet count decreased,6,16190682
9,22.0,Melaena,6,16190682
10,22.0,International normalised ratio increased,6,16190682
0,22.0,Malignant neoplasm progression,5,16190690
1,22.0,Small cell lung cancer,5,16190690
2,22.0,Product use in unapproved indication,6,16190690
0,22.0,Metastases to liver,6,16190709
1,22.0,Breast cancer,6,16190709
2,22.0,Malignant neoplasm progression,6,16190709
3,22.0,Metastases to bone,6,16190709
0,22.0,Malignant neoplasm progression,5,16190742
1,22.0,Sepsis,5,16190742
0,22.0,Abdominal pain,3,16190749
1,22.0,Alanine aminotransferase increased,3,16190749
2,22.0,Vomiting,3,16190749
0,22.0,Pneumonitis,2,16190816
1,22.0,Malignant neoplasm progression,6,16190816
2,22.0,Metastases to central nervous system,6,16190816
0,22.0,Metastasis,6,16190821
1,22.0,Malignant neoplasm progression,6,16190821
2,22.0,Drug ineffective,6,16190821
0,22.0,Death,5,16190837
1,22.0,Blood bilirubin increased,,16190837
0,22.0,Death,5,16190881
0,22.0,Madarosis,3,16190906
1,22.0,Hair texture abnormal,6,16190906
2,22.0,Alopecia,3,16190906
3,22.0,Hair disorder,6,16190906
4,22.0,Hair colour changes,6,16190906
0,22.0,Lactic acidosis,1,16190916
1,22.0,Dyspnoea,2,16190916
2,22.0,Acute kidney injury,2,16190916
3,22.0,Left ventricular hypertrophy,6,16190916
4,22.0,Sinus tachycardia,6,16190916
5,22.0,Peripheral swelling,6,16190916
6,22.0,Diarrhoea,1,16190916
0,22.1,Pulmonary mass,6,16190962
1,22.1,Lymphadenopathy,6,16190962
2,22.1,Cardiomyopathy,6,16190962
3,22.1,Metastases to liver,6,16190962
0,22.0,Product use in unapproved indication,6,16190970
1,22.0,Haemophagocytic lymphohistiocytosis,5,16190970
2,22.0,Autoimmune encephalopathy,5,16190970
0,22.0,Encephalopathy,3,16190997
1,22.0,Aphasia,3,16190997
0,22.0,Second primary malignancy,6,16191000
0,22.0,Clostridium difficile infection,6,16191005
0,22.0,Visual impairment,3,16191015
1,22.0,Amaurosis,3,16191015
2,22.0,Visual field defect,3,16191015
3,22.0,Optic neuritis,3,16191015
0,22.0,Dyspepsia,3,16191022
1,22.0,Vomiting,3,16191022
2,22.0,Lip swelling,2,16191022
3,22.0,Ear pain,2,16191022
4,22.0,Rash pruritic,3,16191022
5,22.0,Nausea,3,16191022
6,22.0,Eye pain,3,16191022
7,22.0,Odynophagia,2,16191022
8,22.0,Asthma,3,16191022
0,22.1,Mental status changes,1,16191068
0,22.0,Neuropathy peripheral,5,16191080
1,22.0,Ileus,5,16191080
2,22.0,Decreased appetite,5,16191080
3,22.0,Weight decreased,5,16191080
4,22.0,Dermatitis acneiform,5,16191080
5,22.0,Neoplasm progression,5,16191080
6,22.0,Anal fistula,5,16191080
0,22.0,Metastases to liver,6,16191088
1,22.0,Malignant neoplasm progression,6,16191088
2,22.0,Metastases to peritoneum,6,16191088
3,22.0,Breast cancer metastatic,6,16191088
4,22.0,Metastases to skin,6,16191088
5,22.0,Metastases to bone,6,16191088
0,22.0,Depressed mood,3,16191102
1,22.0,Asthenia,3,16191102
2,22.0,Malignant neoplasm progression,3,16191102
3,22.0,Decreased appetite,3,16191102
0,22.0,Nephrotic syndrome,6,16191161
1,22.0,Oedema peripheral,3,16191161
0,22.0,Bone marrow failure,6,16191175
1,22.0,Febrile neutropenia,6,16191175
0,22.0,Erythema,1,16191177
1,22.0,Laryngeal oedema,1,16191177
0,22.0,Hair colour changes,6,16191181
1,22.0,Alopecia,6,16191181
2,22.0,Hair texture abnormal,6,16191181
3,22.0,Madarosis,6,16191181
4,22.0,Hair disorder,6,16191181
0,22.0,Monoparesis,2,16191196
1,22.0,Pollakiuria,3,16191196
2,22.0,Gait disturbance,6,16191196
3,22.0,Swelling,6,16191196
4,22.0,Underdose,6,16191196
5,22.0,Oedema peripheral,1,16191196
6,22.0,Asthenia,2,16191196
7,22.0,Prostatic specific antigen increased,6,16191196
0,22.0,Respiratory failure,5,16191250
0,22.0,Interstitial lung disease,5,16191298
1,22.0,Pulmonary alveolar haemorrhage,2,16191298
0,22.0,Death,5,16191314
0,22.0,Blast cell count increased,2,16191331
1,22.0,Haematotoxicity,2,16191331
0,22.0,Malignant neoplasm progression,6,16191334
0,22.0,Peritonitis,5,16191345
0,22.0,Pseudomonas bronchitis,1,16191351
1,22.0,Chronic obstructive pulmonary disease,6,16191351
2,22.0,Pneumonia influenzal,1,16191351
0,22.0,Dyspnoea,6,16191361
0,22.0,Oedema peripheral,2,16191364
1,22.0,Cardiac failure acute,2,16191364
0,22.0,Acute myeloid leukaemia,1,16191500
0,22.0,Death,5,16191597
0,22.1,Pneumonitis,6,16191656
1,22.1,Malignant neoplasm progression,6,16191656
2,22.1,Lung disorder,6,16191656
0,22.0,Cerebrovascular accident,5,16191680
1,22.0,Confusional state,5,16191680
2,22.0,Infection,5,16191680
3,22.0,Malaise,3,16191680
0,22.0,Encephalopathy,3,16191686
1,22.0,Product use in unapproved indication,6,16191686
2,22.0,Aphasia,3,16191686
0,22.0,Lactic acidosis,1,16191691
1,22.0,Acute kidney injury,2,16191691
0,22.0,Dehydration,1,16191709
1,22.0,Acute kidney injury,2,16191709
2,22.0,Shock,1,16191709
3,22.0,Hyperkalaemia,1,16191709
4,22.0,Lactic acidosis,1,16191709
5,22.0,Vomiting,1,16191709
6,22.0,Diarrhoea,1,16191709
7,22.0,Coma,1,16191709
0,22.0,Blast cell count increased,6,16191793
0,22.0,Disease progression,6,16191809
0,22.0,Leukopenia,1,16191837
0,22.0,Vomiting,1,16191855
0,22.0,Teeth brittle,3,16191862
0,22.0,Pneumocystis jirovecii pneumonia,6,16191887
1,22.0,Interstitial lung disease,5,16191887
0,22.0,Constipation,3,16191896
1,22.0,Decreased appetite,3,16191896
2,22.0,Off label use,,16191896
3,22.0,Hypertension,1,16191896
4,22.0,Abdominal pain upper,3,16191896
5,22.0,Fatigue,,16191896
6,22.0,Dry skin,3,16191896
7,22.0,Abdominal pain,1,16191896
8,22.0,Somnolence,3,16191896
9,22.0,Weight decreased,,16191896
10,22.0,Product dose omission,1,16191896
11,22.0,Neuropathy peripheral,3,16191896
0,22.0,Death,5,16191897
0,22.0,Decreased appetite,3,16191902
1,22.0,Coccydynia,3,16191902
2,22.0,Fatigue,3,16191902
3,22.0,Diarrhoea,3,16191902
4,22.0,Dry mouth,3,16191902
5,22.0,Death,5,16191902
0,22.0,Osteonecrosis of jaw,2,16191924
0,22.1,Dermatomyositis,3,16191938
0,22.0,Guillain-Barre syndrome,6,16191987
0,22.0,Pulmonary oedema,3,16192021
1,22.0,Pleural effusion,3,16192021
0,22.0,Neutropenia,1,16192027
1,22.0,Anaemia,1,16192027
2,22.0,Thrombocytopenia,1,16192027
3,22.0,Wrong schedule,6,16192027
4,22.0,Pancytopenia,1,16192027
5,22.0,Medication error,6,16192027
0,22.0,Leukopenia,2,16192048
0,22.0,Pemphigus,2,16192051
0,22.1,Hypophysitis,3,16192062
1,22.1,Adrenal insufficiency,1,16192062
2,22.1,Adrenal disorder,3,16192062
3,22.1,Silent thyroiditis,1,16192062
0,22.0,Cough,5,16192066
1,22.0,Aspartate aminotransferase increased,5,16192066
2,22.0,Pleural effusion,5,16192066
3,22.0,Asthenia,5,16192066
4,22.0,Anxiety,5,16192066
5,22.0,Nausea,5,16192066
6,22.0,Neutrophil count decreased,1,16192066
7,22.0,Dyspnoea,5,16192066
8,22.0,General physical health deterioration,5,16192066
9,22.0,Restlessness,6,16192066
10,22.0,Alanine aminotransferase increased,6,16192066
11,22.0,Malignant neoplasm progression,5,16192066
12,22.0,Neutrophil count decreased,1,16192066
13,22.0,Gamma-glutamyltransferase increased,5,16192066
14,22.0,Breast cancer metastatic,5,16192066
15,22.0,Neutrophil count decreased,1,16192066
16,22.0,Metastases to pleura,5,16192066
17,22.0,Neutrophil count decreased,1,16192066
0,22.0,Hypertransaminasaemia,2,16192083
0,22.0,Blood creatine phosphokinase increased,1,16192092
0,22.0,Cough,6,16192111
1,22.0,Malaise,6,16192111
2,22.0,Infection,6,16192111
3,22.0,Product dose omission,6,16192111
4,22.0,Lower respiratory tract infection,6,16192111
5,22.0,White blood cell count abnormal,6,16192111
6,22.0,Pulmonary mass,6,16192111
7,22.0,Neutrophil count decreased,6,16192111
0,22.0,Weight decreased,3,16192112
1,22.0,Loss of consciousness,1,16192112
2,22.0,Fall,1,16192112
3,22.0,Blood pressure increased,3,16192112
0,22.0,Presyncope,2,16192144
1,22.0,Hypotension,2,16192144
2,22.0,Rash macular,2,16192144
3,22.0,Pruritus generalised,2,16192144
0,22.0,Haemorrhage,5,16192163
1,22.0,Malignant neoplasm progression,5,16192163
2,22.0,Haemoptysis,5,16192163
3,22.0,Shock haemorrhagic,5,16192163
0,22.0,Diastolic dysfunction,6,16192167
1,22.0,Pyrexia,6,16192167
2,22.0,Chest pain,6,16192167
3,22.0,Lip ulceration,6,16192167
4,22.0,Blindness,6,16192167
5,22.0,Dyslipidaemia,6,16192167
6,22.0,Retinal vein thrombosis,6,16192167
7,22.0,Type V hyperlipidaemia,6,16192167
8,22.0,Dyspnoea,6,16192167
9,22.0,Hypothyroidism,6,16192167
10,22.0,Neutropenia,1,16192167
11,22.0,Hypertension,6,16192167
12,22.0,Depression,6,16192167
13,22.0,Non-small cell lung cancer,6,16192167
14,22.0,Headache,6,16192167
15,22.0,Rash,6,16192167
0,22.0,Spinal compression fracture,3,16192170
1,22.0,Malaise,3,16192170
2,22.0,Bronchitis,1,16192170
3,22.0,Pneumonia,1,16192170
0,22.0,Atrioventricular block complete,6,16192189
0,22.0,Diarrhoea,1,16192192
1,22.0,Hypokalaemia,1,16192192
2,22.0,Vomiting,1,16192192
3,22.0,Dehydration,1,16192192
4,22.0,Pyrexia,1,16192192
5,22.0,Abdominal infection,6,16192192
6,22.0,Hyponatraemia,1,16192192
7,22.0,Off label use,6,16192192
0,22.0,Portal vein thrombosis,6,16192193
0,22.0,Portal vein thrombosis,6,16192194
0,22.0,Drug resistance,6,16192210
1,22.0,Pneumonitis,1,16192210
0,22.0,Death,5,16192216
1,22.0,Adverse event,6,16192216
0,22.0,Chest pain,1,16192229
1,22.0,Cholestasis,1,16192229
2,22.0,Dyspnoea,1,16192229
3,22.0,Myocarditis,1,16192229
0,22.0,Hypotension,1,16192257
1,22.0,Hyperhidrosis,1,16192257
0,22.0,Malignant neoplasm progression,6,16192283
1,22.0,Metastasis,6,16192283
2,22.0,Ovarian cancer recurrent,6,16192283
0,22.0,Alopecia,3,16192287
1,22.0,Psychological trauma,6,16192287
0,22.0,Pain,6,16192288
1,22.0,Emotional distress,6,16192288
2,22.0,Anxiety,6,16192288
3,22.0,Impaired quality of life,6,16192288
4,22.0,Alopecia,3,16192288
5,22.0,Psychological trauma,6,16192288
0,22.0,Alopecia,2,16192290
1,22.0,Psychological trauma,6,16192290
0,22.0,Alopecia,3,16192298
1,22.0,Psychological trauma,6,16192298
0,22.0,Alopecia,2,16192302
1,22.0,Psychological trauma,6,16192302
0,22.0,Alopecia,2,16192312
1,22.0,Psychological trauma,6,16192312
0,22.0,Alopecia,3,16192314
1,22.0,Psychological trauma,6,16192314
0,22.0,Alopecia,3,16192319
1,22.0,Psychological trauma,6,16192319
0,22.0,Alopecia,2,16192320
1,22.0,Psychological trauma,6,16192320
0,22.0,Psychological trauma,6,16192337
1,22.0,Alopecia,2,16192337
0,22.0,Alopecia,3,16192339
0,22.0,Alopecia,2,16192341
1,22.0,Psychological trauma,6,16192341
0,22.0,Alopecia,3,16192345
1,22.0,Psychological trauma,6,16192345
0,22.0,Psychological trauma,6,16192346
1,22.0,Alopecia,2,16192346
0,22.0,Alopecia,2,16192348
1,22.0,Psychological trauma,6,16192348
0,22.0,Alopecia,3,16192351
0,22.0,Psychological trauma,6,16192364
1,22.0,Alopecia,2,16192364
0,22.0,Alopecia,2,16192372
1,22.0,Psychological trauma,6,16192372
0,22.0,Alopecia,2,16192373
1,22.0,Psychological trauma,6,16192373
0,22.0,Alopecia,2,16192440
0,22.0,Alopecia,2,16192442
1,22.0,Psychological trauma,6,16192442
0,22.1,Psychological trauma,6,16192451
1,22.1,Alopecia,2,16192451
0,22.0,Off label use,6,16192635
1,22.0,Acute hepatic failure,5,16192635
0,22.0,Hypersensitivity vasculitis,6,16192649
0,22.1,Ascites,5,16192665
1,22.1,Weight increased,2,16192665
2,22.1,Metastases to lymph nodes,5,16192665
3,22.1,Hepatic failure,5,16192665
4,22.1,Hepatic function abnormal,5,16192665
5,22.1,Platelet count decreased,1,16192665
0,22.0,Metastases to central nervous system,6,16192678
0,22.0,Dysphagia,6,16192721
1,22.0,Anxiety,6,16192721
2,22.0,Constipation,6,16192721
3,22.0,Sleep apnoea syndrome,6,16192721
4,22.0,Insomnia,6,16192721
5,22.0,Somnolence,6,16192721
6,22.0,Decreased appetite,2,16192721
7,22.0,Pulmonary embolism,6,16192721
8,22.0,Dyspnoea,6,16192721
9,22.0,Cognitive disorder,6,16192721
10,22.0,Vomiting,6,16192721
11,22.0,Fatigue,6,16192721
12,22.0,Depression,2,16192721
13,22.0,Urinary retention,6,16192721
14,22.0,Delirium,6,16192721
0,22.0,Bladder pain,6,16192729
1,22.0,Amnesia,6,16192729
0,22.0,Reversible cerebral vasoconstriction syndrome,1,16192732
0,22.0,Bone marrow failure,6,16192804
0,22.0,Pyrexia,2,16192885
1,22.0,Blood pressure increased,2,16192885
2,22.0,Chills,2,16192885
3,22.0,Oxygen saturation decreased,2,16192885
0,22.0,Dermatitis bullous,2,16192897
1,22.0,Dermatitis acneiform,2,16192897
2,22.0,Neutropenia,1,16192897
3,22.0,Anaemia,3,16192897
0,22.0,Pleural effusion,5,16192923
0,22.0,Anxiety,6,16192927
1,22.0,Diabetes mellitus inadequate control,2,16192927
2,22.0,Ventricular extrasystoles,6,16192927
3,22.0,Nephrolithiasis,6,16192927
0,22.0,Pelvic fracture,6,16192930
1,22.0,Colitis,2,16192930
2,22.0,Hip fracture,6,16192930
0,22.0,Fatigue,2,16192936
1,22.0,Decreased appetite,2,16192936
2,22.0,Meningioma,2,16192936
0,22.0,Off label use,5,16192939
1,22.0,Death,5,16192939
2,22.0,Intentional product use issue,5,16192939
0,22.0,Liver disorder,1,16192943
0,22.0,Death,5,16192967
0,22.0,Small intestinal obstruction,1,16192971
0,22.0,Neuropathy peripheral,6,16192989
0,22.0,Breast cancer metastatic,6,16193002
0,22.0,Subcutaneous abscess,6,16193003
0,22.0,Type 2 diabetes mellitus,4,16193005
0,22.0,Administration site swelling,1,16193006
1,22.0,Pain in extremity,3,16193006
2,22.0,Infusion related reaction,2,16193006
0,22.0,Gastrointestinal disorder,1,16193010
1,22.0,Bone marrow failure,1,16193010
0,22.0,Disease progression,6,16193074
0,22.0,Vomiting,1,16193099
1,22.0,Febrile neutropenia,1,16193099
2,22.0,Febrile neutropenia,1,16193099
3,22.0,Hypocalcaemia,3,16193099
4,22.0,Diarrhoea,1,16193099
5,22.0,Dyspepsia,3,16193099
6,22.0,Stomatitis,3,16193099
7,22.0,Dizziness,3,16193099
8,22.0,Neutropenia,1,16193099
9,22.0,Anaemia,3,16193099
0,22.0,Cardiac failure acute,2,16193111
1,22.0,Oedema peripheral,2,16193111
0,22.0,Intracranial mass,6,16193218
0,22.0,Peritonitis,5,16193298
1,22.0,Intestinal ischaemia,5,16193298
2,22.0,Sepsis,5,16193298
0,22.0,Aphasia,6,16193334
1,22.0,Antiphospholipid syndrome,2,16193334
0,22.0,Peripheral swelling,2,16193424
1,22.0,Cartilage injury,2,16193424
2,22.0,Joint swelling,2,16193424
3,22.0,Vision blurred,2,16193424
4,22.0,Hip arthroplasty,2,16193424
5,22.0,Chills,2,16193424
6,22.0,Osteonecrosis,2,16193424
7,22.0,Osteoarthritis,2,16193424
8,22.0,Arthralgia,2,16193424
0,22.0,Product dose omission,6,16193482
1,22.0,Product availability issue,6,16193482
2,22.0,No adverse event,6,16193482
0,22.0,Haemoglobin decreased,6,16193665
1,22.0,Pneumonitis,1,16193665
2,22.0,White blood cell count increased,3,16193665
3,22.0,Thrombosis,6,16193665
4,22.0,Pleural effusion,1,16193665
5,22.0,Mucosal inflammation,4,16193665
6,22.0,Fatigue,3,16193665
7,22.0,Cough,6,16193665
8,22.0,Infection,1,16193665
9,22.0,Platelet count increased,3,16193665
10,22.0,Depression,4,16193665
11,22.0,Platelet count decreased,1,16193665
12,22.0,Pyrexia,6,16193665
13,22.0,Lymphoedema,3,16193665
14,22.0,Red blood cell count decreased,1,16193665
0,22.0,Endometrial thickening,3,16193740
1,22.0,Endometrial hyperplasia,3,16193740
0,22.0,Neuropathy peripheral,2,16193803
0,22.0,Lichenoid keratosis,1,16193918
1,22.0,Oedema peripheral,1,16193918
0,22.0,Paraesthesia,3,16193937
1,22.0,Asthenia,3,16193937
2,22.0,Muscle contractions involuntary,3,16193937
3,22.0,Dermatitis acneiform,3,16193937
4,22.0,Hyporeflexia,3,16193937
0,22.0,Hypoaesthesia,6,16193944
0,22.0,Type 2 diabetes mellitus,4,16193948
0,22.1,Abdominal pain upper,1,16193974
1,22.1,Pneumothorax,5,16193974
2,22.1,Malignant neoplasm progression,5,16193974
3,22.1,Cell death,1,16193974
4,22.1,Diarrhoea,1,16193974
5,22.1,Renal cancer metastatic,5,16193974
6,22.1,Inflammation,5,16193974
7,22.1,Cholestasis,1,16193974
8,22.1,Headache,1,16193974
9,22.1,Constipation,1,16193974
0,22.0,Dyspnoea,5,16193993
1,22.0,Interstitial lung disease,5,16193993
0,22.0,Alopecia,3,16193998
1,22.0,Electrocardiogram QT prolonged,1,16193998
2,22.0,Hypokalaemia,1,16193998
3,22.0,Hyponatraemia,6,16193998
0,22.0,Death,5,16194000
0,22.0,Anaemia,1,16194482
1,22.0,Bicytopenia,1,16194482
0,22.0,No adverse event,6,16194523
1,22.0,Off label use,6,16194523
2,22.0,Intentional product use issue,6,16194523
0,22.0,Osteonecrosis of jaw,3,16194571
0,22.0,Fatigue,3,16194582
1,22.0,Asthenia,3,16194582
0,22.0,Disease progression,6,16194714
1,22.0,Feeling abnormal,6,16194714
2,22.0,Pruritus,3,16194714
3,22.0,Colorectal cancer metastatic,6,16194714
4,22.0,Paronychia,3,16194714
0,22.0,Hyperhidrosis,6,16194758
1,22.0,Hypocalcaemia,6,16194758
2,22.0,Auditory disorder,3,16194758
3,22.0,Cardiac function test abnormal,1,16194758
4,22.0,Tooth disorder,3,16194758
5,22.0,Weight decreased,6,16194758
6,22.0,Swelling,3,16194758
7,22.0,Peripheral swelling,3,16194758
8,22.0,Toothache,3,16194758
9,22.0,Immunodeficiency,3,16194758
10,22.0,Product use issue,6,16194758
11,22.0,Hypoacusis,3,16194758
0,22.0,Diarrhoea,,16196543
0,22.0,Drug ineffective,,16196601
0,22.0,Tremor,,16196620
1,22.0,Infusion related reaction,,16196620
2,22.0,Feeling cold,,16196620
0,22.0,Disease progression,,16196685
0,22.0,Thrombosis,,16196706
0,22.0,Haematochezia,,16196805
1,22.0,Arthralgia,,16196805
2,22.0,Constipation,,16196805
3,22.0,Myalgia,,16196805
0,22.0,Therapy cessation,,16196823
1,22.0,Band neutrophil count decreased,,16196823
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16196875
0,22.0,Neuropathy peripheral,,16197065
1,22.0,Breast tumour excision,,16197065
0,22.0,Disease progression,,16197104
0,22.0,Disease progression,,16197111
0,22.0,Haemorrhage,,16197588
0,22.0,Myalgia,,16197590
1,22.0,Product preparation issue,,16197590
2,22.0,Product substitution issue,,16197590
3,22.0,Product quality issue,,16197590
4,22.0,Back pain,,16197590
5,22.0,Fatigue,,16197590
6,22.0,Manufacturing production issue,,16197590
7,22.0,Product formulation issue,,16197590
0,22.0,Depression,,16197812
1,22.0,Panic attack,,16197812
2,22.0,Palpitations,,16197812
3,22.0,Night sweats,,16197812
0,22.0,Unevaluable event,,16270258
0,22.0,Hot flush,,16275108
1,22.0,Chest pain,,16275108
2,22.0,Restless legs syndrome,,16275108
3,22.0,Blood testosterone decreased,,16275108
0,22.0,Death,,16276746
0,22.0,Flatulence,,16276890
1,22.0,Nasal congestion,,16276890
0,22.0,Hospitalisation,,16277154
0,22.0,Lethargy,,16279982
1,22.0,Gastrointestinal disorder,,16279982
0,22.0,Therapy cessation,,16280134
1,22.0,Hospitalisation,,16280134
0,22.0,Back pain,,16280148
0,22.0,Disease progression,,16280251
0,22.0,Death,,16280258
0,22.0,Disease progression,,16280317
1,22.0,Fatigue,,16280317
0,22.0,Nausea,,16280707
1,22.0,Cholelithiasis,,16280707
2,22.0,Pancreatitis,,16280707
3,22.0,Diarrhoea,,16280707
4,22.0,Fatigue,,16280707
0,22.0,Diarrhoea,,16280752
0,22.0,Disease progression,,16280762
1,22.0,Drug ineffective,,16280762
0,22.0,Disease progression,,16280917
0,22.0,Dehydration,,16280919
1,22.0,Diarrhoea,,16280919
0,22.0,Nasopharyngitis,,16280948
1,22.0,Abdominal distension,,16280948
0,22.0,Therapy cessation,,16284870
1,22.0,Disease progression,,16284870
0,22.0,Death,,16285087
0,22.0,Disease progression,,16285663
0,22.0,Epistaxis,,16285970
1,22.0,Rhinorrhoea,,16285970
0,22.0,Sepsis,,16286381
1,22.0,Pneumonia,,16286381
0,22.0,Rash erythematous,,16288629
1,22.0,Rash vesicular,,16288629
0,22.0,Hepatic failure,,16288808
1,22.0,Tachycardia,,16288808
2,22.0,Therapy cessation,,16288808
0,22.0,Disease progression,,16289939
0,22.0,Vomiting,,16290613
1,22.0,Diarrhoea,,16290613
0,22.0,Prostatic specific antigen increased,,16290634
0,22.0,Depression,,16290917
1,22.0,Fatigue,,16290917
0,22.0,Disease progression,,16290927
0,22.0,Cerebrovascular accident,,16291212
0,22.0,Dehydration,,16291374
0,22.0,Dry mouth,,16291375
0,22.0,Infusion related reaction,,16295298
1,22.0,Nausea,,16295298
2,22.0,Posturing,,16295298
3,22.0,Somnolence,,16295298
4,22.0,Blood pressure decreased,,16295298
5,22.0,Dizziness,,16295298
0,22.0,Pulmonary oedema,,16295341
0,22.0,Respiratory distress,,16295524
1,22.0,Flushing,,16295524
2,22.0,Hyperhidrosis,,16295524
3,22.0,Muscle spasms,,16295524
4,22.0,Adverse drug reaction,,16295524
5,22.0,Dysarthria,,16295524
0,22.0,Musculoskeletal pain,,16295531
0,22.0,Unevaluable event,,16296908
0,22.0,Angina pectoris,,16298920
1,22.0,Anaemia,,16298920
2,22.0,Chest pain,,16298920
0,22.0,Cough,,16299160
0,22.0,Full blood count decreased,,16299762
0,22.0,Product use issue,,16299791
0,22.0,Muscle spasms,,16300247
0,22.0,Product use issue,,16302151
0,22.0,Thrombosis,,16303283
0,22.0,Death,,16303535
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16305042
0,22.0,Vomiting,,16305297
1,22.0,Flatulence,,16305297
0,22.0,Malignant neoplasm progression,,16305388
0,22.0,Diarrhoea,,16305424
0,22.0,Dehydration,,16306647
1,22.0,Diarrhoea,,16306647
0,22.0,Spinal cord disorder,,16307909
1,22.0,Tumour compression,,16307909
0,22.0,Sinusitis,,16308074
0,22.0,Product use issue,,16308113
0,22.0,Hepatic enzyme increased,,16308669
0,22.0,Death,,16309142
0,22.0,Irritability,,16309473
1,22.0,Muscular weakness,,16309473
2,22.0,Pollakiuria,,16309473
0,22.0,Death,,16309638
0,22.0,Abdominal pain upper,,16309651
1,22.0,Decreased appetite,,16309651
0,22.0,Disease progression,,16309811
0,22.0,Rash,,16309872
0,22.0,Death,,16313129
0,22.0,Vomiting,,16313303
1,22.0,Diarrhoea,,16313303
2,22.0,Peripheral coldness,,16313303
3,22.0,Feeling abnormal,,16313303
4,22.0,Aphasia,,16313303
5,22.0,Nausea,,16313303
0,22.0,Blood pressure increased,,16313380
0,22.0,Malaise,,16313445
0,22.0,Dry skin,,16313522
1,22.0,Metastases to central nervous system,,16313522
0,22.0,Cellulitis,,16313672
1,22.0,Atrial fibrillation,,16313672
0,22.0,Diarrhoea,,16313794
0,22.0,Hepatitis,,16314536
0,22.0,Cerebrovascular accident,,16314543
0,22.0,Decreased appetite,,16314562
1,22.0,Chromaturia,,16314562
2,22.0,Constipation,,16314562
3,22.0,Peripheral swelling,,16314562
4,22.0,Dizziness,,16314562
0,22.0,Dyspnoea exertional,,16314896
1,22.0,Syncope,,16314896
2,22.0,Bradycardia,,16314896
3,22.0,Aortic stenosis,,16314896
4,22.0,Head injury,,16314896
0,22.0,Pulmonary embolism,,16314974
1,22.0,Sinus tachycardia,,16314974
2,22.0,Troponin T increased,,16314974
3,22.0,Bifascicular block,,16314974
4,22.0,Gastroenteritis,,16314974
5,22.0,Deep vein thrombosis,,16314974
6,22.0,Acute kidney injury,,16314974
0,22.0,Abdominal discomfort,,16319331
0,22.0,Urinary tract infection,,16319957
1,22.0,Wrong schedule,,16319957
0,22.0,Seasonal allergy,,16319967
1,22.0,Upper respiratory tract infection,,16319967
2,22.0,Nasopharyngitis,,16319967
0,22.0,Death,,16320100
0,22.0,Off label use,,16320141
1,22.0,Drug interaction,,16320141
0,22.0,Therapy cessation,,16320501
1,22.0,Gastrointestinal stoma complication,,16320501
0,22.0,White blood cell count decreased,,16321787
1,22.0,Therapy cessation,,16321787
0,22.0,Hypoaesthesia,,16321798
1,22.0,Epistaxis,,16321798
2,22.0,Pain in extremity,,16321798
0,22.0,Drug ineffective,,16321866
0,22.0,Nervous system disorder,,16324448
0,22.0,Peripheral swelling,,16324742
0,22.0,Diarrhoea,,16325419
1,22.0,Product dose omission,,16325419
2,22.0,Erythema,,16325419
3,22.0,Decreased appetite,,16325419
0,22.0,Nervous system disorder,,16325481
1,22.0,Plasmapheresis,,16325481
0,22.0,Dyspepsia,,16326671
0,22.0,Nausea,,16326832
0,22.0,Product dispensing error,,16327351
0,22.0,Pruritus,,16330253
0,22.0,Death,,16331384
0,22.0,Stomatitis,,16331431
1,22.0,Dry mouth,,16331431
2,22.0,Skin fissures,,16331431
0,22.0,Fatigue,,16331670
1,22.0,Insomnia,,16331670
2,22.0,Nausea,,16331670
0,22.0,Nasopharyngitis,,16331703
0,22.0,Asthenia,,16331864
1,22.0,Therapy change,,16331864
2,22.0,Hypotension,,16331864
3,22.0,Diarrhoea,,16331864
0,22.0,Insomnia,,16331868
1,22.0,Headache,,16331868
2,22.0,Drug ineffective,,16331868
3,22.0,Abdominal distension,,16331868
0,22.0,Therapy non-responder,,16331913
1,22.0,Disease progression,,16331913
0,22.0,Death,,16331940
0,22.0,Scratch,,16332037
1,22.0,Skin ulcer,,16332037
2,22.0,Dry skin,,16332037
3,22.0,Pruritus,,16332037
0,22.0,Haemorrhage,,16335350
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16378343
1,22.0,Therapy change,,16378343
0,22.0,Chills,,16378442
1,22.0,Infusion related reaction,,16378442
2,22.0,Rash,,16378442
3,22.0,Erythema,,16378442
0,22.0,Rash,,16378468
0,22.0,Feeling abnormal,,16378487
1,22.0,Fatigue,,16378487
0,22.0,Chest discomfort,,16378604
1,22.0,Throat tightness,,16378604
0,22.0,Paranoia,1,16194854
1,22.0,Lethargy,1,16194854
2,22.0,Anxiety,1,16194854
3,22.0,Off label use,6,16194854
0,22.0,Pneumonitis,3,16194856
1,22.0,Dyspnoea,1,16194856
0,22.0,Off label use,6,16194859
0,22.0,Ventricular extrasystoles,2,16194903
0,22.0,Radiation pneumonitis,1,16194911
0,22.0,Basedow^s disease,6,16194930
1,22.0,Gastric disorder,6,16194930
2,22.0,Angiopathy,6,16194930
0,22.0,Metastases to central nervous system,6,16194982
1,22.0,Infusion related reaction,1,16194982
2,22.0,Suspected product quality issue,6,16194982
3,22.0,Epilepsy,1,16194982
4,22.0,General physical health deterioration,6,16194982
5,22.0,Coma,2,16194982
0,22.0,Pneumonia aspiration,6,16195008
1,22.0,Autoimmune thyroiditis,6,16195008
0,22.0,Cellulitis,3,16195048
0,22.0,Off label use,6,16195058
0,22.0,Osteonecrosis,6,16195068
0,22.0,Retinopathy,6,16195079
0,22.0,Peripheral swelling,6,16195083
1,22.0,Malignant neoplasm progression,6,16195083
2,22.0,Dysphagia,3,16195083
3,22.0,Product use in unapproved indication,6,16195083
4,22.0,Dyspnoea,6,16195083
0,22.1,Gait disturbance,1,16195093
1,22.1,Platelet count decreased,1,16195093
2,22.1,Muscular weakness,6,16195093
3,22.1,Urinary incontinence,1,16195093
0,22.0,Disorientation,6,16195105
1,22.0,Restlessness,6,16195105
0,22.0,Off label use,6,16195159
0,22.0,Bone marrow failure,6,16195165
1,22.0,Gastrointestinal disorder,6,16195165
0,22.0,Chest pain,1,16195172
1,22.0,Cardiac disorder,3,16195172
0,22.0,Electrolyte imbalance,6,16195180
1,22.0,Spinal fracture,6,16195180
2,22.0,Death,5,16195180
3,22.0,Febrile neutropenia,6,16195180
4,22.0,Urinary tract infection,6,16195180
5,22.0,Asthenia,6,16195180
6,22.0,Colorectal cancer metastatic,6,16195180
7,22.0,Fall,6,16195180
0,22.0,Bladder disorder,6,16195201
1,22.0,Pleural effusion,6,16195201
2,22.0,Pelvic inflammatory disease,6,16195201
3,22.0,Spinal osteoarthritis,6,16195201
4,22.0,Accessory spleen,6,16195201
5,22.0,Pneumonitis,6,16195201
6,22.0,Inflammation,6,16195201
0,22.0,Septic shock,6,16195205
1,22.0,Death,5,16195205
2,22.0,Neutropenia,6,16195205
3,22.0,Malignant neoplasm progression,6,16195205
0,22.0,Malignant neoplasm progression,6,16195211
1,22.0,Fatigue,6,16195211
0,22.0,Malignant neoplasm progression,6,16195215
1,22.0,Colon cancer recurrent,6,16195215
2,22.0,Death,5,16195215
0,22.0,Febrile neutropenia,6,16195221
1,22.0,Metastases to liver,6,16195221
2,22.0,Death,5,16195221
3,22.0,Malignant neoplasm progression,6,16195221
0,22.0,Ejection fraction decreased,3,16195224
0,22.0,Diarrhoea,6,16195255
1,22.0,Febrile neutropenia,6,16195255
2,22.0,Polyneuropathy,6,16195255
0,22.0,Fatigue,6,16195262
1,22.0,Malignant neoplasm progression,6,16195262
2,22.0,Colon cancer recurrent,6,16195262
0,22.0,Intentional product use issue,5,16195265
1,22.0,Death,5,16195265
2,22.0,Off label use,5,16195265
0,22.0,Malignant neoplasm progression,6,16195286
1,22.0,Pain in extremity,6,16195286
0,22.0,Death,5,16195296
1,22.0,Malignant neoplasm progression,6,16195296
0,22.0,Surgery,6,16195310
1,22.0,Product use issue,6,16195310
0,22.0,Hepatic function abnormal,1,16195329
0,22.0,Systemic scleroderma,6,16195334
0,22.0,Mitral valve disease,6,16195373
1,22.0,Bradycardia,2,16195373
2,22.0,Asthenia,2,16195373
3,22.0,Ill-defined disorder,6,16195373
4,22.0,Cardiac disorder,6,16195373
5,22.0,Fatigue,6,16195373
0,22.0,Death,5,16195398
0,22.0,Flushing,6,16195410
1,22.0,Hyperpyrexia,1,16195410
0,22.0,Vomiting,1,16195426
1,22.0,Infusion related reaction,1,16195426
2,22.0,Myalgia,1,16195426
3,22.0,Malaise,1,16195426
4,22.0,Back pain,1,16195426
0,22.0,Gastrointestinal anastomotic leak,6,16195437
0,22.0,Metastases to central nervous system,6,16195439
1,22.0,Embolism,6,16195439
2,22.0,Rash,6,16195439
3,22.0,Radiation necrosis,6,16195439
0,22.0,Febrile neutropenia,5,16195440
1,22.0,Ileus paralytic,1,16195440
2,22.0,Varicella zoster oesophagitis,6,16195440
3,22.0,Pain,6,16195440
4,22.0,Constipation,6,16195440
5,22.0,Neutropenia,6,16195440
6,22.0,Leukopenia,6,16195440
0,22.0,Protein urine present,6,16195505
1,22.0,Device dislocation,6,16195505
2,22.0,Intestinal obstruction,6,16195505
3,22.0,Vomiting,6,16195505
4,22.0,Gastrointestinal disorder,6,16195505
0,22.0,Blood alkaline phosphatase increased,6,16195519
1,22.0,Aspartate aminotransferase increased,6,16195519
0,22.1,Leukocytosis,1,16195654
0,22.0,Rash generalised,1,16195658
0,22.0,Vomiting,6,16195668
1,22.0,Malignant neoplasm progression,6,16195668
2,22.0,Nausea,6,16195668
3,22.0,Diarrhoea,6,16195668
0,22.0,Facial paralysis,1,16195681
1,22.0,Aphasia,1,16195681
2,22.0,Brain oedema,1,16195681
0,22.0,Lung disorder,1,16195742
0,22.0,Neurotoxicity,1,16195820
0,22.0,Cerebral haemorrhage,2,16195863
0,22.0,Acute respiratory distress syndrome,6,16195876
1,22.0,Multiple organ dysfunction syndrome,6,16195876
2,22.0,Asthenia,6,16195876
3,22.0,Mucosal inflammation,3,16195876
4,22.0,Septic shock,5,16195876
5,22.0,Haematochezia,6,16195876
6,22.0,Sepsis,5,16195876
7,22.0,Bone marrow failure,3,16195876
8,22.0,Diarrhoea,3,16195876
9,22.0,Stomatitis,3,16195876
0,22.0,Optic neuritis,3,16195881
1,22.0,Amaurosis,3,16195881
2,22.0,Visual impairment,3,16195881
3,22.0,Visual field defect,3,16195881
0,22.0,Drug ineffective,6,16195894
1,22.0,Tooth fracture,6,16195894
0,22.0,Dry mouth,2,16196112
1,22.0,Urine analysis abnormal,2,16196112
2,22.0,Asthenia,1,16196112
3,22.0,Gait disturbance,1,16196112
4,22.0,Fatigue,6,16196112
5,22.0,Drug ineffective,6,16196112
0,22.0,Non-small cell lung cancer,3,16196123
0,22.0,Concussion,6,16196132
1,22.0,Fall,6,16196132
2,22.0,Speech disorder,6,16196132
3,22.0,Dizziness,6,16196132
4,22.0,Prostatic specific antigen increased,6,16196132
5,22.0,Treatment noncompliance,6,16196132
0,22.0,Terminal state,6,16196191
0,22.0,Infusion related reaction,1,16196196
0,22.0,Meningitis,6,16196201
0,22.0,Enteritis,2,16196218
0,22.0,Metastases to bone,6,16196220
1,22.0,Malignant neoplasm progression,6,16196220
2,22.0,Breast cancer,6,16196220
3,22.0,Metastases to liver,6,16196220
0,22.0,Mucosal inflammation,5,16196221
1,22.0,Labelled drug-drug interaction medication error,1,16196221
2,22.0,Unintentional use for unapproved indication,1,16196221
3,22.0,Folliculitis,6,16196221
4,22.0,Multiple organ dysfunction syndrome,5,16196221
5,22.0,Pancytopenia,5,16196221
0,22.0,Diarrhoea,2,16196264
0,22.0,Death,5,16196272
0,22.0,Suicide attempt,6,16196283
1,22.0,Flat affect,1,16196283
2,22.0,Cognitive disorder,3,16196283
3,22.0,Confusional state,1,16196283
4,22.0,Psychiatric decompensation,6,16196283
5,22.0,Derealisation,3,16196283
6,22.0,Metrorrhagia,1,16196283
7,22.0,Fear,1,16196283
8,22.0,Asthenia,1,16196283
9,22.0,Crying,1,16196283
10,22.0,Hypersomnia,3,16196283
11,22.0,Affect lability,3,16196283
0,22.1,Oral lichen planus,1,16196299
1,22.1,Lichen planus,1,16196299
0,22.0,Colorectal cancer recurrent,5,16196304
1,22.0,Drug interaction,5,16196304
0,22.0,Metastases to spinal cord,6,16196309
0,22.1,Alopecia,3,16196390
1,22.1,Anaemia,1,16196390
2,22.1,Metastasis,6,16196390
3,22.1,Pancytopenia,1,16196390
4,22.1,Neutropenia,1,16196390
5,22.1,Muscle discomfort,3,16196390
6,22.1,Fatigue,3,16196390
7,22.1,Hot flush,3,16196390
8,22.1,Lip dry,1,16196390
0,22.0,Lymphadenopathy mediastinal,6,16196427
1,22.0,Pneumonitis,6,16196427
0,22.0,Intestinal obstruction,6,16196428
1,22.0,Pelvic fluid collection,6,16196428
0,22.0,Product use in unapproved indication,6,16196497
1,22.0,Diarrhoea,1,16196497
2,22.0,Arthralgia,1,16196497
0,22.0,Off label use,6,16196523
0,22.0,Hyponatraemia,3,16196526
1,22.0,Asthenia,1,16196526
2,22.0,Vomiting,1,16196526
0,22.0,Thrombocytopenia,1,16196536
1,22.0,Acute kidney injury,1,16196536
2,22.0,Neutropenia,1,16196536
3,22.0,Leukopenia,1,16196536
4,22.0,Pancytopenia,1,16196536
0,22.0,Dyspnoea,6,16196580
0,22.0,Periodontal disease,6,16196588
0,22.0,Gastric ulcer,6,16196594
0,22.0,Death,5,16196628
0,22.0,Off label use,6,16196658
0,22.0,Hyperbilirubinaemia,1,16196670
0,22.0,Dermatitis acneiform,3,16196717
1,22.0,Dry skin,3,16196717
2,22.0,Aphthous ulcer,3,16196717
3,22.0,Gastrointestinal motility disorder,3,16196717
4,22.0,Asthenia,3,16196717
0,22.0,Gastrointestinal oedema,2,16196748
1,22.0,Intestinal dilatation,2,16196748
2,22.0,Ascites,2,16196748
3,22.0,Abdominal pain,2,16196748
0,22.0,Malignant neoplasm progression,6,16196750
1,22.0,Pneumonia aspiration,5,16196750
2,22.0,Intestinal obstruction,5,16196750
0,22.0,Metastases to liver,6,16196753
1,22.0,Malignant neoplasm progression,6,16196753
2,22.0,Metastases to bone,6,16196753
0,22.0,Dyspnoea,1,16196755
1,22.0,Erythema,1,16196755
0,22.0,Wrong technique in product usage process,6,16196799
1,22.0,Breakthrough pain,6,16196799
2,22.0,Product adhesion issue,6,16196799
3,22.0,Drug ineffective,6,16196799
0,22.0,Stevens-Johnson syndrome,2,16196819
0,22.0,Injection site pain,6,16196836
1,22.0,Pain,6,16196836
2,22.0,Nausea,6,16196836
0,22.1,Sinus arrest,2,16196857
1,22.1,Hyperkalaemia,2,16196857
2,22.1,Product prescribing error,6,16196857
3,22.1,Acute kidney injury,2,16196857
4,22.1,Prescribed overdose,6,16196857
5,22.1,Rhythm idioventricular,2,16196857
0,22.0,Altered state of consciousness,6,16196884
1,22.0,Multiple organ dysfunction syndrome,5,16196884
2,22.0,Nephrogenic anaemia,2,16196884
3,22.0,Renal impairment,2,16196884
0,22.0,Death,5,16196951
0,22.0,Death,5,16196955
0,22.0,Neutropenia,6,16196978
1,22.0,White blood cell count decreased,6,16196978
0,22.0,Alopecia,3,16197008
1,22.0,Madarosis,3,16197008
0,22.1,Hair disorder,3,16197009
1,22.1,Hair colour changes,3,16197009
2,22.1,Alopecia,3,16197009
3,22.1,Hair texture abnormal,3,16197009
0,22.1,Hair colour changes,3,16197060
1,22.1,Alopecia,3,16197060
2,22.1,Hair texture abnormal,3,16197060
3,22.1,Hair disorder,3,16197060
0,22.0,Alopecia,3,16197088
1,22.0,Hair colour changes,3,16197088
2,22.0,Hair disorder,3,16197088
3,22.0,Madarosis,3,16197088
4,22.0,Hair texture abnormal,3,16197088
0,22.0,Hair disorder,3,16197090
1,22.0,Hair texture abnormal,3,16197090
2,22.0,Hair colour changes,3,16197090
3,22.0,Madarosis,3,16197090
4,22.0,Alopecia,3,16197090
0,22.0,Neoplasm progression,3,16197093
0,22.0,Fatigue,6,16197100
1,22.0,Drug hypersensitivity,6,16197100
2,22.0,Asthenia,6,16197100
3,22.0,Paraesthesia,6,16197100
0,22.0,Hair disorder,3,16197107
1,22.0,Hair colour changes,3,16197107
2,22.0,Madarosis,3,16197107
3,22.0,Hair texture abnormal,3,16197107
4,22.0,Alopecia,3,16197107
0,22.0,Full blood count decreased,1,16197150
1,22.0,Diarrhoea,6,16197150
0,22.0,Alopecia,3,16197158
1,22.0,Hair texture abnormal,3,16197158
2,22.0,Anxiety,6,16197158
3,22.0,Depression,6,16197158
4,22.0,Madarosis,3,16197158
5,22.0,Hair disorder,3,16197158
6,22.0,Affective disorder,6,16197158
7,22.0,Hair colour changes,3,16197158
0,22.0,Alopecia,3,16197180
0,22.1,Madarosis,3,16197186
1,22.1,Hair disorder,3,16197186
2,22.1,Hair texture abnormal,3,16197186
3,22.1,Hair colour changes,3,16197186
4,22.1,Alopecia,3,16197186
0,22.0,Diarrhoea,2,16197232
1,22.0,Vomiting,2,16197232
2,22.0,Acute kidney injury,2,16197232
0,22.0,Hair disorder,3,16197239
1,22.0,Madarosis,3,16197239
2,22.0,Hair texture abnormal,3,16197239
3,22.0,Alopecia,3,16197239
4,22.0,Hair colour changes,3,16197239
0,22.0,Hair disorder,3,16197244
1,22.0,Alopecia,3,16197244
2,22.0,Hair texture abnormal,3,16197244
3,22.0,Hair colour changes,3,16197244
0,22.0,Neoplasm progression,6,16197285
1,22.0,Feeling abnormal,6,16197285
0,22.1,Madarosis,3,16197302
1,22.1,Alopecia,3,16197302
0,22.0,Sarcoidosis,3,16197322
0,22.0,Pancytopenia,6,16197328
1,22.0,White blood cell count decreased,6,16197328
0,22.1,Malaise,6,16197331
1,22.1,Decreased appetite,6,16197331
2,22.1,Platelet count decreased,6,16197331
3,22.1,Febrile neutropenia,2,16197331
4,22.1,Herpes zoster,6,16197331
5,22.1,Thyroid disorder,2,16197331
6,22.1,Pleural effusion,6,16197331
0,22.0,Interstitial lung disease,2,16197357
0,22.0,Pulmonary hypertension,6,16197358
1,22.0,Interstitial lung disease,2,16197358
2,22.0,Hepatic cyst,6,16197358
0,22.0,Hypersensitivity,1,16197385
1,22.0,Dyspnoea,1,16197385
2,22.0,Chest discomfort,1,16197385
3,22.0,Anxiety,1,16197385
0,22.0,Hypoxia,1,16197395
1,22.0,Malaise,1,16197395
2,22.0,Hypotension,1,16197395
3,22.0,Erythema,1,16197395
4,22.0,Hypersensitivity,1,16197395
0,22.0,Aspartate aminotransferase increased,6,16197479
1,22.0,Alanine aminotransferase increased,6,16197479
0,22.0,Pyrexia,1,16197510
1,22.0,Body temperature increased,1,16197510
0,22.0,Gastric perforation,1,16197520
0,22.0,Chest pain,1,16197524
1,22.0,Pyrexia,1,16197524
2,22.0,Hypoxia,1,16197524
3,22.0,Metabolic acidosis,1,16197524
0,22.1,Pleural effusion,6,16197529
1,22.1,Hepatic function abnormal,5,16197529
2,22.1,Encephalopathy,6,16197529
3,22.1,Breast cancer,5,16197529
0,22.0,Small cell carcinoma,6,16197534
1,22.0,Malignant neoplasm progression,6,16197534
0,22.0,Influenza,5,16197562
0,22.0,Neutrophil count decreased,6,16197587
1,22.0,White blood cell count decreased,6,16197587
2,22.0,Cognitive disorder,6,16197587
3,22.0,Pain,2,16197587
4,22.0,Gait disturbance,6,16197587
5,22.0,Dehydration,6,16197587
6,22.0,Product dose omission,6,16197587
7,22.0,Nausea,6,16197587
8,22.0,Weight decreased,6,16197587
9,22.0,Neoplasm progression,6,16197587
10,22.0,Malaise,6,16197587
0,22.0,Anxiety,6,16197592
1,22.0,Depression,6,16197592
2,22.0,Suicidal ideation,6,16197592
3,22.0,Sleep disorder,6,16197592
4,22.0,Headache,6,16197592
0,22.0,Neoplasm progression,1,16197601
1,22.0,Back pain,1,16197601
0,22.0,Haematotoxicity,6,16197606
1,22.0,Toxicity to various agents,6,16197606
0,22.0,Product use in unapproved indication,6,16197636
0,22.0,Death,5,16197648
0,22.0,No adverse event,3,16197651
0,22.0,Febrile neutropenia,1,16197653
1,22.0,Transaminases increased,2,16197653
2,22.0,Hypotension,1,16197653
3,22.0,Drug interaction,1,16197653
4,22.0,Stomatitis,1,16197653
5,22.0,Periorbital oedema,1,16197653
0,22.0,Drug hypersensitivity,6,16197660
0,22.0,Mechanical ileus,3,16197672
1,22.0,Pleural effusion,3,16197672
0,22.0,Prostatic specific antigen increased,3,16197701
1,22.0,Blood alkaline phosphatase increased,3,16197701
2,22.0,Therapy cessation,6,16197701
0,22.1,Renal pain,5,16197730
1,22.1,Type 2 diabetes mellitus,1,16197730
2,22.1,Breast cancer metastatic,5,16197730
3,22.1,Syncope,1,16197730
4,22.1,Myopathy,1,16197730
5,22.1,Abdominal distension,5,16197730
6,22.1,Hyperglycaemia,1,16197730
7,22.1,Ascites,5,16197730
8,22.1,Malignant neoplasm progression,5,16197730
9,22.1,Pneumonia influenzal,1,16197730
0,22.0,Therapy partial responder,6,16197741
1,22.0,Septic shock,6,16197741
2,22.0,Neutropenia,6,16197741
0,22.0,Subarachnoid haemorrhage,1,16197747
0,22.0,Pneumothorax,6,16197767
1,22.0,Pulmonary oedema,6,16197767
2,22.0,Anal haemorrhage,1,16197767
0,22.0,Therapy partial responder,6,16197781
1,22.0,Pneumonia,6,16197781
2,22.0,Neutropenic sepsis,6,16197781
0,22.0,Confusional state,3,16197803
0,22.0,Febrile neutropenia,3,16197868
1,22.0,Thrombocytopenia,3,16197868
0,22.0,Gastrointestinal disorder,1,16197871
1,22.0,Gastrointestinal toxicity,6,16197871
2,22.0,Proteinuria,3,16197871
0,22.0,Nausea,1,16197877
0,22.0,Acute myeloid leukaemia,3,16197905
0,22.0,Disease progression,5,16197990
0,22.0,Autoimmune hepatitis,1,16198064
0,22.0,Confusional state,1,16198069
1,22.0,Lethargy,1,16198069
2,22.0,Fatigue,1,16198069
3,22.0,Hydronephrosis,1,16198069
4,22.0,Oedema peripheral,1,16198069
5,22.0,Ascites,1,16198069
6,22.0,Acute kidney injury,1,16198069
7,22.0,Chest discomfort,1,16198069
8,22.0,Infection,1,16198069
9,22.0,Chest pain,1,16198069
10,22.0,Compression fracture,1,16198069
11,22.0,Constipation,1,16198069
12,22.0,Dyspnoea,1,16198069
13,22.0,Urinary tract infection,1,16198069
14,22.0,Neoplasm progression,1,16198069
15,22.0,Pain,1,16198069
16,22.0,Pleural effusion,1,16198069
17,22.0,Renal impairment,1,16198069
18,22.0,Delirium,1,16198069
19,22.0,Oedema,1,16198069
20,22.0,Pulmonary embolism,1,16198069
21,22.0,Toxicity to various agents,1,16198069
0,22.1,Lower gastrointestinal haemorrhage,1,16198078
0,22.0,Pneumonia,6,16198127
0,22.0,Acute kidney injury,2,16198154
1,22.0,Myositis,2,16198154
0,22.0,Pleural effusion,6,16198159
1,22.0,Atelectasis,6,16198159
0,22.0,Anaphylactic shock,2,16198171
1,22.0,Hypoxia,2,16198171
0,22.0,Hormone-refractory prostate cancer,6,16198187
1,22.0,Malignant neoplasm progression,6,16198187
2,22.0,Metastases to bone,6,16198187
3,22.0,Spinal pain,6,16198187
4,22.0,Prostatic specific antigen increased,2,16198187
5,22.0,Prostate cancer,6,16198187
0,22.0,Bone pain,6,16198198
1,22.0,Fatigue,6,16198198
2,22.0,Decreased appetite,6,16198198
0,22.0,Peripheral sensorimotor neuropathy,3,16198202
1,22.0,Acute motor-sensory axonal neuropathy,3,16198202
2,22.0,Demyelinating polyneuropathy,3,16198202
3,22.0,Superinfection bacterial,1,16198202
4,22.0,Toxicity to various agents,1,16198202
5,22.0,Depression,2,16198202
6,22.0,Rash,3,16198202
7,22.0,Neuropathy peripheral,3,16198202
8,22.0,Conjunctivitis,1,16198202
9,22.0,Erythema,3,16198202
10,22.0,Staphylococcal infection,3,16198202
11,22.0,Face oedema,1,16198202
0,22.0,Generalised erythema,2,16198237
1,22.0,Anaphylactic shock,2,16198237
0,22.0,Pleural effusion,2,16198257
1,22.0,Decreased appetite,6,16198257
2,22.0,Tri-iodothyronine decreased,6,16198257
3,22.0,Malaise,3,16198257
4,22.0,Dyspnoea,2,16198257
0,22.0,Acute kidney injury,3,16198271
0,22.0,Neoplasm progression,6,16198272
0,22.0,Anaemia,6,16198310
1,22.0,Vomiting,6,16198310
2,22.0,Neutropenia,6,16198310
3,22.0,Cardiotoxicity,6,16198310
4,22.0,Leukopenia,6,16198310
5,22.0,Constipation,6,16198310
6,22.0,Off label use,6,16198310
7,22.0,Product use issue,6,16198310
8,22.0,Thrombocytopenia,6,16198310
9,22.0,Diarrhoea,6,16198310
10,22.0,Incorrect dose administered,6,16198310
11,22.0,Neurotoxicity,6,16198310
12,22.0,Nausea,6,16198310
0,22.1,Chills,6,16198319
1,22.1,Dry mouth,6,16198319
2,22.1,Intentional dose omission,6,16198319
3,22.1,Taste disorder,6,16198319
4,22.1,Dysgeusia,6,16198319
5,22.1,Arthralgia,6,16198319
0,22.0,Malignant urinary tract neoplasm,2,16198336
1,22.0,Haematinuria,2,16198336
2,22.0,Hypokalaemia,2,16198336
3,22.0,Incorrect dose administered,6,16198336
4,22.0,Off label use,6,16198336
5,22.0,Angina pectoris,2,16198336
6,22.0,Acute myocardial infarction,6,16198336
0,22.1,Death,5,16198339
1,22.1,Emphysema,6,16198339
2,22.1,Cardiomyopathy,2,16198339
3,22.1,Interstitial lung disease,2,16198339
4,22.1,Atrial fibrillation,2,16198339
5,22.1,Cardiac failure,2,16198339
0,22.0,Pneumonia,2,16198340
1,22.0,Cardiac failure,2,16198340
2,22.0,Hypokalaemia,1,16198340
0,22.0,Osteonecrosis of jaw,3,16198353
0,22.0,Malignant neoplasm progression,5,16198399
1,22.0,Hypoaesthesia,3,16198399
2,22.0,Nausea,1,16198399
3,22.0,Pleural effusion,3,16198399
4,22.0,Infectious pleural effusion,1,16198399
5,22.0,Weight decreased,3,16198399
6,22.0,Urinary retention,1,16198399
0,22.0,Lactic acidosis,1,16198405
1,22.0,Diarrhoea,1,16198405
2,22.0,Left ventricular hypertrophy,6,16198405
3,22.0,Acute kidney injury,2,16198405
4,22.0,Sinus tachycardia,6,16198405
0,22.0,Oral pain,6,16198426
0,22.0,Pulmonary function test decreased,2,16198447
0,22.0,Anxiety,6,16198464
1,22.0,Alopecia,3,16198464
0,22.0,Hepatitis,6,16198497
0,22.0,Off label use,6,16198504
1,22.0,Product dose omission,6,16198504
